Phoenix Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.2M Buy
113,278
+7,371
+7% +$792K 0.16% 74
2025
Q1
$10.7M Sell
105,907
-28,112
-21% -$2.84M 0.16% 91
2024
Q4
$12M Sell
134,019
-45,033
-25% -$4.02M 0.16% 84
2024
Q3
$15M Buy
179,052
+54,439
+44% +$4.56M 0.22% 73
2024
Q2
$9.6M Sell
124,613
-19,647
-14% -$1.51M 0.15% 85
2024
Q1
$9.88M Buy
144,260
+16,423
+13% +$1.13M 0.14% 80
2023
Q4
$8.27M Sell
127,837
-6,252
-5% -$405K 0.14% 77
2023
Q3
$7.09M Sell
134,089
-10,268
-7% -$543K 0.13% 77
2023
Q2
$7.79M Buy
144,357
+38,884
+37% +$2.1M 0.16% 64
2023
Q1
$5.27M Buy
105,473
+37,787
+56% +$1.89M 0.12% 84
2022
Q4
$3.13M Buy
67,686
+17,926
+36% +$830K 0.06% 105
2022
Q3
$1.96M Sell
49,760
-2,699
-5% -$106K 0.04% 150
2022
Q2
$1.96M Sell
52,459
-9,794
-16% -$365K 0.04% 164
2022
Q1
$2.76M Buy
62,253
+51,524
+480% +$2.28M 0.05% 166
2021
Q4
$460K Sell
10,729
-2,299
-18% -$98.6K 0.01% 288
2021
Q3
$570K Sell
13,028
-228
-2% -$9.98K 0.01% 302
2021
Q2
$572K Sell
13,256
-423
-3% -$18.3K 0.01% 264
2021
Q1
$533K Sell
13,679
-3,749
-22% -$146K 0.01% 308
2020
Q4
$617K Buy
17,428
+9,025
+107% +$320K 0.02% 247
2020
Q3
$299K Buy
+8,403
New +$299K 0.01% 261